Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (351-360 of 405) with videos related to

Pageof 41
Sort By:
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
BMC Immunology|June 28, 2005
Standardization of cytokine flow cytometry assaysHolden T Maecker, Aline Rinfret, Patricia D'Souza, et al.
Cell Reports|June 14, 2025
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Pageof 41

Showing results (351-360 of 405) with videos related to

Sort By:
Pageof 41
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
BMC Immunology|June 28, 2005
Standardization of cytokine flow cytometry assaysHolden T Maecker, Aline Rinfret, Patricia D'Souza, et al.
Cell Reports|June 14, 2025
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Pageof 41